Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Merck |
---|---|
Information provided by: | Merck |
ClinicalTrials.gov Identifier: | NCT00242476 |
This study will assess the effectiveness of an investigational drug in elderly subjects with low vitamin D levels.
Condition | Intervention | Phase |
---|---|---|
Vitamin D Deficiency |
Drug: MK0822A |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double Blind (Subject, Investigator), Placebo Control, Parallel Assignment, Efficacy Study |
Official Title: | A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 16-Week Study to Assess the Effect of Vitamin D3 8400IU Once Weekly on Body Sway and Neuromuscular Function in Men and Women Aged 70 Years or Older |
Enrollment: | 216 |
Study Start Date: | September 2005 |
Study Completion Date: | July 2006 |
Primary Completion Date: | July 2006 (Final data collection date for primary outcome measure) |
Ages Eligible for Study: | 70 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Responsible Party: | Merck & Co., Inc. ( Executive Vice President, Clinical and Quantitative Sciences ) |
Study ID Numbers: | 2005_089, 0822A-009 |
Study First Received: | October 18, 2005 |
Last Updated: | June 10, 2009 |
ClinicalTrials.gov Identifier: | NCT00242476 History of Changes |
Health Authority: | United States: Food and Drug Administration |
Vitamin D Deficiency Cholecalciferol Vitamin D Malnutrition Vitamin D3 |
Avitaminosis Vitamins Nutrition Disorders Calciferol Deficiency Diseases |
Vitamin D Deficiency Malnutrition Avitaminosis Nutrition Disorders Deficiency Diseases |